🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, single-arm, multi-center, phase II study of SHR-1701...
Status
Unknown
Location
Tumor Hospital of the Chinese Academy of Medical Sciences
Start Date
2021-05-07
Trial ID
NCT04650633
Treatments Being Tested
This single arm study will assess the efficacy and safety of rituximab in c...
Status
Completed
Location
Hospital De Txagorritxu; Servicio de Hematologia
Start Date
2007-11-21
Trial ID
NCT00545714
Treatments Being Tested
This phase II/III trial is studying the side effects and how well giving da...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2008-07-14
Trial ID
NCT00720109
Treatments Being Tested
The purpose of this study is to evaluate the effects, good and bad of a new...
Status
Unknown
Location
Northwestern University
Start Date
2015-10-28
Trial ID
NCT02481310
The purpose of this study is to evaluate consistency in terms of the immune...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-11-09
Trial ID
NCT01702428
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2006-05
Trial ID
NCT00369681
Treatments Being Tested
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
SGCs are rare (less than 1% of head and neck cancers) and include many mali...
Status
Completed
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2014-12
Trial ID
NCT02857712
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
University Hospital Brno
Start Date
2004-02
Trial ID
NCT00290667
The purpose of this study is to determine if EMD 1201081 in combination wit...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2009-12
Trial ID
NCT01040832
Treatments Being Tested